Amylyx Pharmaceuticals, Inc. ($AMLX)
Filing Information
| Accession Number | 0001193125-26-390510 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 14, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
10,028
Total Value
$324,868.11
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Common Stock | โ | Sep 10, 2026 | Sale | 7,947 | $32.21 | $256,003.86 | 280,145 | Direct | โ | View Details | |
Chief Medical Officer | Common Stock | โ | Sep 10, 2026 | Sale | 2,081 | $33.09 | $68,864.24 | 278,064 | Direct | โ | View Details |